These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7820122)

  • 1. Comparison of displacemental potencies of terazosin enantiomers for alpha 1-adrenoceptor subtypes.
    Maruyama K; Ohkura N; Yagi Y; Nagatomo T
    Biol Pharm Bull; 1994 Aug; 17(8):1126-9. PubMed ID: 7820122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actions of terazosin and its enantiomers at subtypes of alpha 1- and alpha 2-adrenoceptors in vitro.
    Hancock AA; Buckner SA; Ireland LM; Knepper SM; Kerwin JF
    J Recept Signal Transduct Res; 1995; 15(7-8):863-85. PubMed ID: 8673721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-adrenoceptor properties of terazosin HCl and its enantiomers in the human prostate and canine brain.
    Meretyk S; Tang R; Shapiro E; Kyncl JJ; Lepor H
    Prostate; 1992; 20(2):159-65. PubMed ID: 1347941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamsulosin: assessment of affinity of 3H-prazosin bindings to two alpha1-adrenoceptor subtypes (alpha1H and alpha1L) in bovine prostate and rat heart and brain.
    Maruyama K; Nakamura T; Yoshihara T; Fukutomi J; Sugiyama K; Hattorim K; Ohnuki T; Watanabe K; Nagatomo T
    Gen Pharmacol; 1998 Oct; 31(4):597-600. PubMed ID: 9792222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]R-terazosin binds selectively to alpha1-adrenoceptors over alpha2-adrenoceptors - comparison with racemic [3H]terazosin and [3H]prazosin.
    Ireland LM; Cain JC; Rotert G; Thomas S; Shoghi S; Hancock AA; Kerwin JF
    Eur J Pharmacol; 1997 May; 327(1):79-86. PubMed ID: 9185839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamsulosin: assessment of affinityof (3)H-P razosin binding to two alpha-1- adrenoceptor subtypes in the canine aorta.
    Nakamura T; Maruyama K; Ohnuki T; Hattori K; Watanabe K; Nagatomo T
    Pharmacology; 1999 Nov; 59(5):234-8. PubMed ID: 10529655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
    Maruyama K; Fukutomi J; Chiba T; Yamaguchi M; Takeda M; Hattori K; Nagatomo T
    Gen Pharmacol; 1996 Dec; 27(8):1377-81. PubMed ID: 9304410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional evidence equating the pharmacologically-defined alpha 1A- and cloned alpha 1C-adrenoceptor: studies in the isolated perfused kidney of rat.
    Blue DR; Bonhaus DW; Ford AP; Pfister JR; Sharif NA; Shieh IA; Vimont RL; Williams TJ; Clarke DE
    Br J Pharmacol; 1995 May; 115(2):283-94. PubMed ID: 7670730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of guinea-pig, bovine and rat alpha 1-adrenoceptor subtypes.
    Büscher R; Heeks C; Taguchi K; Michel MC
    Br J Pharmacol; 1996 Feb; 117(4):703-11. PubMed ID: 8646417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of alpha1-adrenoceptor subtypes in rat aorta and prostate.
    Maruyama K; Suzuki M; Tsuchiya M; Makara Y; Hattori K; Ohnuki T; Watanabe K; Nagatomo T
    Pharmacology; 1998 Aug; 57(2):88-95. PubMed ID: 9691228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediation of noradrenaline-induced contractions of rat aorta by the alpha 1B-adrenoceptor subtype.
    Testa R; Guarneri L; Poggesi E; Simonazzi I; Taddei C; Leonardi A
    Br J Pharmacol; 1995 Feb; 114(4):745-50. PubMed ID: 7773533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.
    Hatano A; Tang R; Walden PD; Lepor H
    Eur J Pharmacol; 1996 Oct; 313(1-2):135-43. PubMed ID: 8905340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
    Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
    Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioligand binding studies of alpha 1-adrenoceptor subtypes in rat heart.
    Michel MC; Hanft G; Gross G
    Br J Pharmacol; 1994 Feb; 111(2):533-8. PubMed ID: 7911718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of alpha 1-adrenoceptor subtypes in rat heart: a binding study.
    Noguchi H; Muraoka R; Kigoshi S; Muramatsu I
    Br J Pharmacol; 1995 Mar; 114(5):1026-30. PubMed ID: 7780636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of alpha1-adrenoceptor subtypes in the pig.
    Wikberg-Matsson A; Wikberg JE; Uhlén S
    Eur J Pharmacol; 1998 Apr; 347(2-3):301-9. PubMed ID: 9653897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-adrenoceptor subtypes in rat aorta and mesenteric small arteries are preserved during left ventricular dysfunction post-myocardial infarction.
    Stassen FR; Willemsen MJ; Janssen GM; DeMey JG
    Cardiovasc Res; 1997 Mar; 33(3):706-13. PubMed ID: 9093543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha adrenergic binding properties of terazosin in the human prostate adenoma and canine brain.
    Lepor H; Baumann M; Shapiro E
    J Urol; 1988 Sep; 140(3):664-7. PubMed ID: 2457715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential alpha1-adrenoceptor labeling by [3H]prazosin and [3H]tamsulosin.
    Michel MC; Goepel M
    Eur J Pharmacol; 1998 Jan; 342(1):85-92. PubMed ID: 9544796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding and functional characterization of alpha1-adrenoceptor subtypes in the rat prostate.
    Hiraoka Y; Ohmura T; Oshita M; Watanabe Y; Morikawa K; Nagata O; Kato H; Taniguchi T; Muramatsu I
    Eur J Pharmacol; 1999 Jan; 366(1):119-26. PubMed ID: 10064160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.